XML 91 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 25, 2012
Dec. 27, 2011
Dec. 28, 2010
Cash flows from operations:      
Net Income $ 173,448,000 $ 135,952,000 $ 111,599,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 90,939,000 79,899,000 68,673,000
Stock-based compensation expense 9,094,000 9,861,000 9,558,000
Tax benefit from exercise of stock options (8,587,000) (4,994,000) (3,603,000)
Increase (Decrease) in Deferred Income Taxes 20,334,000 1,351,000 (4,660,000)
Other 4,470,000 2,423,000 1,114,000
Changes in operating assets and liabilities, excluding the effect of acquisitions:      
Trade and other accounts receivable, net (31,414,000) (16,369,000) (13,180,000)
Inventories (2,440,000) (2,183,000) (1,540,000)
Prepaid expenses (10,995,000) (7,323,000) (7,694,000)
Deposits and other 161,000 117,000 (2,337,000)
Accounts payable (6,513,000) 8,538,000 929,000
Accrued expenses 49,246,000 19,630,000 61,891,000
Deferred rent 5,718,000 6,081,000 4,603,000
Other long-term liabilities (4,005,000) 3,906,000 12,281,000
Net cash provided by operating activities 289,456,000 236,889,000 237,634,000
Cash flows from investing activities:      
Additions to property and equipment (152,328,000) (107,932,000) (82,226,000)
Acquisitions, net of cash acquired (47,951,000) (44,377,000) (52,177,000)
Proceeds from sale of bakery-cafes 4,538,000 115,000 2,204,000
Net cash used in investing activities (195,741,000) (152,194,000) (132,199,000)
Cash flows from financing activities:      
Repurchase of common stock (31,566,000) (96,605,000) (153,492,000)
Exercise of employee stock options 4,455,000 3,193,000 25,551,000
Tax benefit from exercise of stock options 8,587,000 4,994,000 3,603,000
Proceeds from issuance of common stock under employee benefit plans 2,462,000 2,040,000 1,802,000
Debt Issuance Cost (1,097,000) 0 0
Payment of Deferred Acquisition Holdback (2,055,000) (4,976,000) 0
Net cash (used in) provided by financing activities (19,214,000) (91,354,000) (122,536,000)
Net (decrease) increase in cash and cash equivalents 74,501,000 (6,659,000) (17,101,000)
Cash and Cash Equivalents at beginning of period 222,640,000 229,299,000  
Cash and Cash Equivalents, at Carrying Value $ 297,141,000 $ 222,640,000 $ 229,299,000